Syneron Medical (ELOS) Reports Q4 Loss of $0.50
Tweet Send to a FriendGet Alerts ELOS Hot Sheet
Trade ELOS Now!
Syneron Medical Ltd. (NASDAQ: ELOS) reports Q4 loss of $0.50, versus the analyst estimate of $0.05. Revenue for the quarter was $14.2 million, versus the consensus of $24.97 million.
You May Also Be Interested In
- NetApp (NTAP) Tops Q4 EPS by 1c; Boosts Buyback, Plans Job Cuts, Initiates Dividend
- Medtronic, Inc. (MDT) Tops Q4 EPS by 7c; Guides FY14
- Analog Devices, Inc. (ADI) Reports In-Line Q2 EPS, Guidance Light
Create E-mail Alert Related Categories
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

